Clinical and Microbiological Characteristics of Community-Onset Carbapenem-Resistant Enterobacteriaceae Isolates

References

• Ben-David D, Kordevani R, Keller N, et al. Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections. Clin Microbiol Infect. 2012;18(1):54–60. doi:10.1111/j.1469-0691.2011.03478.x
   PubMed Web of Science ®Google Scholar
• Ben-David D, Kordevani R, Keller N, et al. Carbapenem-resistant Enterobacteriaceae: a strategic roadmap for infection control-corrigendum. Infect Control Hosp Epidemiol. 2017;38(9):1136.28720159
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States.2019:148 Available from: www.cdc.gov/DrugResistance/Biggest-Threats.html. Accessed 91, 2020.
   Google Scholar
• Guh AY, Bulens SN, Mu Y, et al. Epidemiology of Carbapenem-resistant Enterobacteriaceae in 7 US communities, 2012-2013. JAMA. 2015;314(14):1479–1487. doi:10.1001/jama.2015.1248026436831
   PubMed Web of Science ®Google Scholar
• Tang HJ, Hsieh CF, Chang PC, et al. Clinical significance of community- and healthcare-acquired carbapenem-resistant Enterobacteriaceae isolates. PLoS One. 2016;11(3):1–8.
   Web of Science ®Google Scholar
• Kellya AM, Barun Mathemab ELL, Larson EL. Carbapenem-resistant Enterobacteriaceae in the community: a scoping review. Int J Antimicrob Agents. 2017;50(2):127–134. doi:10.1016/j.ijantimicag.2017.03.01228647532
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Facility guidance for control of carbapenem-resistant Enterobacteriaceae (CRE). 2019 Available from: https://www.cdc.gov/hai/organisms/cre/technical-info.html. Accessed 91, 2020.
   Google Scholar
• Friedman ND, Kaye KS, Stout JE, et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002;137(10):791–797. doi:10.7326/0003-4819-137-10-200211190-0000712435215
   PubMed Web of Science ®Google Scholar
• Quan J, Zhao D, Liu L, et al. High prevalence of ESBL-producing Escherichia coli and Klebsiella pneumoniae in community-onset bloodstream infections in China. J Antimicrob Chemother. 2017;72(1):273–280. doi:10.1093/jac/dkw37227624571
   PubMed Web of Science ®Google Scholar
• Kang CI, Wi YM, Ko KS, et al. Outcomes and risk factors for mortality in community-onset bacteremia caused by extended-spectrum beta-lactamase-producing Escherichia coli, with a special emphasis on antimicrobial therapy. Scand J Infect Dis. 2013;45(7):519–525. doi:10.3109/00365548.2013.77547923509913
   PubMed Web of Science ®Google Scholar
• CLSI. Performance standards for antimicrobial susceptibility Testing 29th In: CLSI Supplement M100. Wayne, PA: Clinical and Laboratory Standards Institute; 2019.
   Google Scholar
• The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 9.0.2019 Available from: http://www.eucast.org. Accessed 91, 2020.
   Google Scholar
• Feng Y, Wei L, Zhu S, et al. Handwashing sinks as the source of transmission of ST16 carbapenem-resistant Klebsiella pneumoniae, an international high-risk clone, in an intensive care unit. J Hosp Infect. 2020;104(4):492‐496. doi:10.1016/j.jhin.2019.10.006
   Web of Science ®Google Scholar
• Thaden JT, Lewis SS, Hazen KC, et al. Rising rates of carbapenem-resistant enterobacteriaceae in community hospitals: a mixed-methods review of epidemiology and microbiology practices in a network of community hospitals in the southeastern United States. Infect Control Hosp Epidemiol. 2014;35(8):978–983. doi:10.1086/67715725026612
   PubMed Web of Science ®Google Scholar
• Brennan BM, Coyle JR, Marchaim D, et al. Statewide surveillance of carbapenem-resistant enterobacteriaceae in Michigan. Infect Control Hosp Epidemiol. 2014;35(4):342–349. doi:10.1086/67561124602937
   PubMed Web of Science ®Google Scholar
• Sánchez-López J, Cantón R. Current status of ESKAPE microorganisms in Spain: epidemiology and resistance phenotypes. Rev Esp Quimioter. 2019;32(Suppl2):27‐31.
   Google Scholar
• Alexopoulou A, Papadopoulos N, Eliopoulos DG, et al. Increasing frequency of gram-positive cocci and gram-negative multidrug-resistant bacteria in spontaneous bacterial peritonitis. Liver Int. 2013;33(7):975–981. doi:10.1111/liv.1215223522099
   PubMed Web of Science ®Google Scholar
• Lohiya A, Kant S, Kapil A, Gupta SK, Misra P, Rai SK. Pattern of antibiotic resistance among community derived isolates of Enterobacteriaceae using urine sample: a study from Northern India. J Clin Diagn Res. 2015;9(7):LC15–LC19. doi:10.7860/JCDR/2015/14230.6254
   Google Scholar
• JD T, Gottlieb T, DH M, GW C, JC P, JM B. Australian Group on antimicrobial resistance community-onset gram-negative surveillance program annual report, 2010. Commun Dis Intell Q Rep. 2013;37(3):E219–E223.24890957
   PubMedGoogle Scholar
• Zhang P, Shi Q, Hu H, et al. Emergence of ceftazidime/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China. Clin Microbiol Infect. 2020;26(1):124.e1–124.e4. doi:10.1016/j.cmi.2019.08.020
   Web of Science ®Google Scholar
• Zhang R, Liu L, Zhou H, et al. Nationwide surveillance of clinical Carbapenem-resistant Enterobacteriaceae (CRE) strains in China. EBioMedicine. 2017;19:98–106. doi:10.1016/j.ebiom.2017.04.03228479289
   PubMed Web of Science ®Google Scholar
• Zmarlicka MT, Nailor MD, Nicolau DP. Impact of the New Delhi metallo-beta-lactamase on beta-lactam antibiotics. Infect Drug Resist. 2015;8:297–309. doi:10.2147/IDR.S3918626345624
   PubMed Web of Science ®Google Scholar
• Walsh TR, Weeks J, Livermore DM, Toleman MA. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect Dis. 2011;11(5):355–362. doi:10.1016/S1473-3099(11)70059-721478057
   PubMed Web of Science ®Google Scholar
• Hamzaoui Z, Ocampo-Sosa A, Fernandez Martinez M, et al. Role of association of OmpK35 and OmpK36 alteration and bla and/or bla genes in conferring carbapenem resistance among non-carbapenemase-producing Klebsiella pneumoniae. Int J Antimicrob Agents. 2018;52(6):898–905. doi:10.1016/j.ijantimicag.2018.03.02029621592
   PubMed Web of Science ®Google Scholar
• Zimmerman FS, Assous MV, Bdolah-Abram T, Lachish T, Yinnon AM, Wiener-Well Y. Duration of carriage of carbapenem-resistant Enterobacteriaceae following hospital discharge. Am J Infect Control. 2013;41(3):190–194. doi:10.1016/j.ajic.2012.09.02023449280
   PubMed Web of Science ®Google Scholar
• Shahid M. Environmental dissemination of NDM-1: time to act sensibly. Lancet Infect Dis. 2011;11(5):334–335. doi:10.1016/S1473-3099(11)70074-321478055
   PubMed Web of Science ®Google Scholar